Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | |
| transdebates [2026/01/29 08:49] – admin | transdebates [2026/01/29 09:09] (current) – admin |
|---|
| |
| |
| For instance, the paper "Clinical guidelines for children and adolescents experiencing gender dysphoria or incongruence: a systematic review of guideline quality" (https://adc.bmj.com/content/archdischild/109/Suppl_2/s65.full.pdf?with-ds=yes) applies OQA3 grading system, which is meant for randomized control studies, to studies of hormone therapy. Since hormone studies are not randomized trials due to ethical concerns, the rating should not be applied to the studies. | For instance, the paper "Clinical guidelines for children and adolescents experiencing gender dysphoria or incongruence: a systematic review of guideline quality" (https://adc.bmj.com/content/archdischild/109/Suppl_2/s65.full.pdf?with-ds=yes) applies AGREE II grading system to studies for hormone therapy. This scale is objective, and how results were obtained in the article was not mentioned. |
| |
